TOKYO/ROLLE - Japanese genetic testing leader A.D.A.M. Innovations and AI healthcare technology company SOPHiA GENETICS (NASDAQ:SOPH), currently valued at $292.62 million and trading near its ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." When it came time to start a family, Sarah Elizabeth Orlando, 33, knew she would go about it differently.

A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return within 18 months of treatment, a study has found. This method picks up ...

Veda N. Giri, MD, outlines alternative care delivery models that could help improve access to genetic testing for prostate cancer. In a recent interview with Urology Times®, Veda N. Giri, MD, outlined ...

NeuroClin - formerly known as Glasgow Memory Clinic - has partnered with Advance Tests to bring to market Scotland’s first commercially available blood biomarker test for the detection of early ...

The study highlights the benefits a robust genetic testing program can have, which ultimately has the potential to improve outcomes ATTRv is caused by more than 130 known mutations in the TTR gene and ...